What do we gain from the sixth coronary heart disease drug?
about
Improving secondary prevention in coronary bypass patients: closing the audit loopPrescribing behaviour according to Dutch and European guidelines on the management of hypercholesterolaemia (1992-1999)Institutional corruption of pharmaceuticals and the myth of safe and effective drugs.Prevention of coronary heart disease: is a cure too expensive?
P2860
What do we gain from the sixth coronary heart disease drug?
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
What do we gain from the sixth coronary heart disease drug?
@en
What do we gain from the sixth coronary heart disease drug?
@nl
type
label
What do we gain from the sixth coronary heart disease drug?
@en
What do we gain from the sixth coronary heart disease drug?
@nl
prefLabel
What do we gain from the sixth coronary heart disease drug?
@en
What do we gain from the sixth coronary heart disease drug?
@nl
P2860
P1433
P1476
What do we gain from the sixth coronary heart disease drug?
@en
P2093
Rebecca N Warburton
P2860
P304
P356
10.1136/BMJ.327.7426.1237
P407
P577
2003-11-01T00:00:00Z